Bayer, Inc.
🇨🇦Canada
Clinical Trials
3
Active:3
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Gadopentetic Acid Dimeglumine Salt Injection
- Product Name
- 马根维显
- Approval Number
- 国药准字HJ20160597
- Approval Date
- Jul 5, 2021
NMPA
Gadopentetic Acid Dimeglumine Salt Injection
- Product Name
- 马根维显
- Approval Number
- 国药准字HJ20160598
- Approval Date
- Jul 5, 2021
NMPA
Gadopentetic Acid Dimeglumine Salt Injection
- Product Name
- 马根维显
- Approval Number
- 国药准字HJ20160593
- Approval Date
- Jul 5, 2021
NMPA
Gadopentetic Acid Dimeglumine Salt Injection
- Product Name
- 马根维显
- Approval Number
- 国药准字HJ20160595
- Approval Date
- Jul 5, 2021
NMPA
Gadopentetic Acid Dimeglumine Salt Injection
- Product Name
- 马根维显
- Approval Number
- 国药准字HJ20160594
- Approval Date
- Jul 5, 2021
NMPA
Gadopentetic Acid Dimeglumine Salt Injection
- Product Name
- 马根维显
- Approval Number
- 国药准字HJ20160596
- Approval Date
- Jul 5, 2021
NMPA
Clinical Trials
No trials found
News
No news found